Noise measurement

Temozolomide in Combination With NF-κB Inhibitor Significantly Disrupts the Glioblastoma Multiforme Spheroid Formation

Author(s): Naze G. Avci, Nitin Tandon, Yasemin M. Akay, Yoshua Esquenazi, Hui Xia, Jay-Jiguang Zhu, Metin Akay, Lisa H. Schmitt
Temozolomide in Combination With NF-κB Inhibitor Significantly Disrupts the Glioblastoma Multiforme Spheroid Formation 742 558 IEEE Open Journal of Engineering in Medicine and Biology (OJEMB)

Glioblastoma multiforme (GBM) is the most common malignant primary brain tumor, accounting for 50% of all cases. GBM patients have a five-year survival rate of merely 5.6% and a median…

read more